Clinical studies investigating the use of leuprorelin for prostate cancer in Asia
Background: Leuprorelin is a well-established treatment for prostate cancer (PCa); however, there is limited information on its use in Asian males. This review of English language publications between January 2000 and 2016 describes the outcomes of clinical trials on leuprorelin in Asian males with...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-03-01
|
| Series: | Prostate International |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S228788821930025X |